Amirhossein Sahebkar

234.8k total citations · 19 hit papers
1.9k papers, 69.4k citations indexed

About

Amirhossein Sahebkar is a scholar working on Molecular Biology, Surgery and Molecular Medicine. According to data from OpenAlex, Amirhossein Sahebkar has authored 1.9k papers receiving a total of 69.4k indexed citations (citations by other indexed papers that have themselves been cited), including 606 papers in Molecular Biology, 362 papers in Surgery and 320 papers in Molecular Medicine. Recurrent topics in Amirhossein Sahebkar's work include Curcumin's Biomedical Applications (300 papers), Lipoproteins and Cardiovascular Health (215 papers) and MicroRNA in disease regulation (93 papers). Amirhossein Sahebkar is often cited by papers focused on Curcumin's Biomedical Applications (300 papers), Lipoproteins and Cardiovascular Health (215 papers) and MicroRNA in disease regulation (93 papers). Amirhossein Sahebkar collaborates with scholars based in Iran, Australia and United States. Amirhossein Sahebkar's co-authors include Maciej Banach, Yunes Panahi, Habib Yaribeygi, Tannaz Jamialahmadi, Thomas P. Johnston, Matteo Pirro, Stephen L. Atkin, Alexandra E. Butler, Muhammed Majeed and Thozhukat Sathyapalan and has published in prestigious journals such as Advanced Materials, SHILAP Revista de lepidopterología and Journal of the American College of Cardiology.

In The Last Decade

Amirhossein Sahebkar

1.8k papers receiving 68.3k citations

Hit Papers

Macrophage plasticity, polarization, and function in heal... 2016 2026 2019 2022 2018 2017 2018 2020 2016 1000 2.0k 3.0k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Amirhossein Sahebkar Iran 127 22.9k 11.9k 9.2k 8.4k 7.3k 1.9k 69.4k
Bharat B. Aggarwal United States 166 48.7k 2.1× 26.3k 2.2× 3.8k 0.4× 16.0k 1.9× 3.6k 0.5× 574 104.9k
Gautam Sethi Singapore 125 26.2k 1.1× 3.3k 0.3× 2.3k 0.3× 4.5k 0.5× 1.3k 0.2× 615 48.2k
Carl Nathan United States 115 23.9k 1.0× 1.8k 0.2× 4.3k 0.5× 22.2k 2.6× 1.5k 0.2× 318 73.0k
David A. Brenner United States 132 20.1k 0.9× 922 0.1× 9.0k 1.0× 7.1k 0.8× 4.3k 0.6× 517 59.5k
Masayuki Yamamoto Japan 169 85.7k 3.7× 987 0.1× 6.2k 0.7× 11.1k 1.3× 2.5k 0.3× 1.4k 119.9k
Lanjuan Li China 92 16.7k 0.7× 2.3k 0.2× 3.6k 0.4× 2.4k 0.3× 662 0.1× 888 38.7k
Tim R. Mosmann United States 53 22.7k 1.0× 901 0.1× 3.2k 0.3× 20.7k 2.5× 1.5k 0.2× 124 75.3k
Chen Chen China 88 19.5k 0.9× 515 0.0× 3.7k 0.4× 4.2k 0.5× 3.3k 0.4× 2.5k 51.4k
Chi‐Tang Ho United States 108 18.2k 0.8× 1.7k 0.1× 1.2k 0.1× 1.6k 0.2× 3.1k 0.4× 1.2k 54.8k
Maciej Banach Poland 80 4.5k 0.2× 899 0.1× 10.0k 1.1× 2.2k 0.3× 5.1k 0.7× 987 28.9k

Countries citing papers authored by Amirhossein Sahebkar

Since Specialization
Citations

This map shows the geographic impact of Amirhossein Sahebkar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amirhossein Sahebkar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amirhossein Sahebkar more than expected).

Fields of papers citing papers by Amirhossein Sahebkar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amirhossein Sahebkar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amirhossein Sahebkar. The network helps show where Amirhossein Sahebkar may publish in the future.

Co-authorship network of co-authors of Amirhossein Sahebkar

This figure shows the co-authorship network connecting the top 25 collaborators of Amirhossein Sahebkar. A scholar is included among the top collaborators of Amirhossein Sahebkar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amirhossein Sahebkar. Amirhossein Sahebkar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nejabat, Mojgan, Farzin Hadizadeh, Wael Almahmeed, & Amirhossein Sahebkar. (2025). Effects of PCSK9 inhibitors on cancer, diabetes, and cardiovascular diseases. Drug Discovery Today. 30(3). 104316–104316. 2 indexed citations
2.
Oroojalian, Fatemeh, et al.. (2024). Stimuli-responsive nanotheranostic systems conjugated with AIEgens for advanced cancer bio-imaging and treatment. Journal of Controlled Release. 373. 766–802. 11 indexed citations
3.
Kesharwani, Prashant, et al.. (2024). Exploring the evolutionary links: Innate immunity in bacteria and eukaryotes. Process Biochemistry. 147. 240–256. 2 indexed citations
4.
Taleghani, Akram, et al.. (2024). Evaluation of antimicrobial and antioxidant effects of silver nanoparticles synthesized with leaves of Lepidium draba L.. SHILAP Revista de lepidopterología. 17(3). 101004–101004. 7 indexed citations
5.
Ataei, Mahshid, et al.. (2024). An overview of the efficacy of inhaled curcumin: a new mode of administration for an old molecule. Expert Opinion on Drug Delivery. 1–16. 2 indexed citations
6.
Pashirzad, Mehran, Prashant Kesharwani, & Amirhossein Sahebkar. (2024). The clinical prognostic significance of miR-140–5p expression in patients with cancer: A Meta and Bioinformatic analysis. Pathology - Research and Practice. 261. 155475–155475. 1 indexed citations
7.
Chatterjee, Rana, Abdulrhman Alsayari, Shadma Wahab, et al.. (2024). Small molecules targeting mitochondria as an innovative approach to cancer therapy. Cellular Signalling. 124. 111396–111396. 2 indexed citations
8.
Kesharwani, Prashant, et al.. (2024). Dendrimer-Encapsulated Curcumin: Illuminating pathways to cancer treatment excellence. European Polymer Journal. 218. 113358–113358. 4 indexed citations
9.
Mahmoudi, Ali, Amin Jalili, Seyed Hamid Aghaee‐Bakhtiari, et al.. (2024). Analysis of the therapeutic potential of miR-124 and miR-16 in non-alcoholic fatty liver disease. Journal of Diabetes and its Complications. 38(4). 108722–108722. 1 indexed citations
10.
Sahebkar, Amirhossein & Maciej Banach. (2024). Transforming hypercholesterolemia management: Spotlight on PCSK9 peptide vaccines. Cell Reports Medicine. 5(9). 101726–101726. 3 indexed citations
11.
Enayati, Ayesheh, et al.. (2023). The Effect of Curcumin on the Gut-Brain Axis: Therapeutic Implications. Journal of Neurogastroenterology and Motility. 29(4). 409–418. 9 indexed citations
12.
Hadizadeh, Alireza, et al.. (2023). COVID-19, G protein-coupled receptor, and renin-angiotensin system autoantibodies: Systematic review and meta-analysis. Autoimmunity Reviews. 22(9). 103402–103402. 9 indexed citations
13.
Patoulias, Dimitrios, Djordje S. Popovic, Anca Pantea Stoian, et al.. (2023). Effect of semaglutide versus other glucagon-like peptide-1 receptor agonists on cardio-metabolic risk factors in patients with type 2 diabetes: A systematic review and meta-analysis of head-to-head, phase 3, randomized controlled trials. Journal of Diabetes and its Complications. 37(8). 108529–108529. 20 indexed citations
14.
Ganjali, Shiva, Maryam Matbou Riahi, Khadijeh Mahboobnia, et al.. (2023). An in vitro investigation of the effects of Urolithins A and B on low-density lipoprotein uptake and its regulatory genes. European Heart Journal. 44(Supplement_2). 2 indexed citations
15.
Saghafi, Fatemeh, Ebrahim Salehifar, Pouneh Ebrahimi, et al.. (2023). Evaluation of the effect of CYP2D6*3, *4,*10, and *17 polymorphisms on the pharmacokinetic of tamoxifen and its metabolites in patients with hormone-positive breast cancer. Journal of Pharmaceutical and Biomedical Analysis. 238. 115839–115839. 1 indexed citations
16.
Aramouni, Karl, Abdullah Shaito, Manal Fardoun, et al.. (2023). Biochemical and cellular basis of oxidative stress: Implications for disease onset. Journal of Cellular Physiology. 238(9). 1951–1963. 54 indexed citations
17.
Gupta, Akash Kumar, Arif Nadaf, Nazeer Hasan, et al.. (2023). Dasatinib: a potential tyrosine kinase inhibitor to fight against multiple cancer malignancies. Medical Oncology. 40(6). 173–173. 15 indexed citations
18.
Mahmoudi, Ali, Alexandra E. Butler, Maciej Banach, Tannaz Jamialahmadi, & Amirhossein Sahebkar. (2023). Identification of Potent Small-Molecule PCSK9 Inhibitors Based on Quantitative Structure-Activity Relationship, Pharmacophore Modeling, and Molecular Docking Procedure. Current Problems in Cardiology. 48(6). 101660–101660. 5 indexed citations
19.
Hosseini, Azar, Mohaddeseh Sadat Alavi, Arezoo Rajabian, et al.. (2023). Psidium guajava induces cytotoxicity in human malignant glioblastoma cell line: Role of reactive oxygen species. Toxicology in Vitro. 89. 105567–105567. 5 indexed citations
20.
Tajbakhsh, Amir, Milad Iranshahy, Javad Asili, et al.. (2020). Naphthoquinone Derivatives Isolated from Plants: Recent Advances in Biological Activity. Mini-Reviews in Medicinal Chemistry. 20(19). 2019–2035. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026